Cargando…
113: SPECIFIC TARGETING OF HER2-POSITIVE BREAST CANCER CELL LINE (SK-BR3) USING IDARUBICIN-LOADED ANTI-HER2 IMMUNOLIPOSOME
Cytotoxic chemotherapy drugs which are used for treating malignant cells cannot distinguish between normal and cancerous cells. This would lead to adverse side effects. Moreover, drug resistance is another major problem of the classical chemotherapy during the treatment period. Recently, various the...
Autores principales: | Pourshohod, Aminollah, Zeinali, Majid, Afrakhte, Moslem, Jamalan, Mostafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759544/ http://dx.doi.org/10.1136/bmjopen-2016-015415.113 |
Ejemplares similares
-
Improvement of Targeted Chemotherapy of HER2-positive Ovarian Malignant Cell Line by Z(HER2)-Idarubicin Conjugate: An in vitro Study
por: Siavoshinia, Leila, et al.
Publicado: (2021) -
1: A CONTENT ANALYSIS OF PEDIATRIC INFORMATION IN IRANIAN NEWSPAPERS
por: Farashbandi, Firoozeh Zare, et al.
Publicado: (2017) -
39: CONNECTING THE DOTS BETWEEN BEST EVIDENCES REGARDING SOCIAL DETERMINANTS OF PATIENTS OUTCOMES AND HEALTH CARE POLICY MAKING
por: Pezeshki, Mohammad Zakaria
Publicado: (2017) -
181: INFORMATION PRESCRIPTION FOR HEART FAILURE PATIENTS; A RANDOMIZED CONTROLLED TRIAL
por: Gavgani, Vahideh Zarea, et al.
Publicado: (2017) -
173: EFFECTIVENESS OF COMMUNITY AND SCHOOL- BASED INTERVENTIONS ON CONTROL AND PREVENTION OF TOBACCO USE IN ADOLESCENTS: A RANDOMIZED COMMUNITY INTERVENTION TRIAL
por: Khayyati, Fariba, et al.
Publicado: (2017)